The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer

T. A. Fregene, P. S. Khanuja, P. A. Gimotty, C. Kellogg, J. George, Kenneth Pienta

Research output: Contribution to journalArticle

Abstract

Angiogenesis in early stage breast cancer has been suggested to be an independent prognostic factor for metastasis and overall survival. We retrospectively studied 316 cases of early breast cancer with a mean follow-up period of 94 months to determine the role of angiogenesis as a prognostic factor in breast cancer utilizing a Factor VIII immuno-histochemical assay. In a univariate analysis, patients with microvessel counts in the lower 25th percentile had significantly better overall disease-free survival than patients in the upper quartiles (p <0.017). In a multivariate analysis of disease-free survival, microvessel counts did not add to prognostic information when controlling for estrogen receptor status and lymph node status, but did add prognostic information when controlling for tumor size.

Original languageEnglish (US)
Pages (from-to)1437-1445
Number of pages9
JournalInternational Journal of Oncology
Volume5
Issue number6
StatePublished - 1994
Externally publishedYes

Fingerprint

Microvessels
Estrogen Receptors
Disease-Free Survival
Lymph Nodes
Breast Neoplasms
Neoplasm Metastasis
Neoplasms
Factor VIII
Multivariate Analysis
Survival

Keywords

  • angiogenesis
  • breast cancer
  • counts
  • microvessel
  • prognostic factor

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer. / Fregene, T. A.; Khanuja, P. S.; Gimotty, P. A.; Kellogg, C.; George, J.; Pienta, Kenneth.

In: International Journal of Oncology, Vol. 5, No. 6, 1994, p. 1437-1445.

Research output: Contribution to journalArticle

@article{e8a4890ae570473b81f8e1ec5f23ee67,
title = "The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer",
abstract = "Angiogenesis in early stage breast cancer has been suggested to be an independent prognostic factor for metastasis and overall survival. We retrospectively studied 316 cases of early breast cancer with a mean follow-up period of 94 months to determine the role of angiogenesis as a prognostic factor in breast cancer utilizing a Factor VIII immuno-histochemical assay. In a univariate analysis, patients with microvessel counts in the lower 25th percentile had significantly better overall disease-free survival than patients in the upper quartiles (p <0.017). In a multivariate analysis of disease-free survival, microvessel counts did not add to prognostic information when controlling for estrogen receptor status and lymph node status, but did add prognostic information when controlling for tumor size.",
keywords = "angiogenesis, breast cancer, counts, microvessel, prognostic factor",
author = "Fregene, {T. A.} and Khanuja, {P. S.} and Gimotty, {P. A.} and C. Kellogg and J. George and Kenneth Pienta",
year = "1994",
language = "English (US)",
volume = "5",
pages = "1437--1445",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "6",

}

TY - JOUR

T1 - The relationship of microvessel counts to tumor size, estrogen receptor status, lymph node metastasis, and disease-free survival in patients with stage I and II breast cancer

AU - Fregene, T. A.

AU - Khanuja, P. S.

AU - Gimotty, P. A.

AU - Kellogg, C.

AU - George, J.

AU - Pienta, Kenneth

PY - 1994

Y1 - 1994

N2 - Angiogenesis in early stage breast cancer has been suggested to be an independent prognostic factor for metastasis and overall survival. We retrospectively studied 316 cases of early breast cancer with a mean follow-up period of 94 months to determine the role of angiogenesis as a prognostic factor in breast cancer utilizing a Factor VIII immuno-histochemical assay. In a univariate analysis, patients with microvessel counts in the lower 25th percentile had significantly better overall disease-free survival than patients in the upper quartiles (p <0.017). In a multivariate analysis of disease-free survival, microvessel counts did not add to prognostic information when controlling for estrogen receptor status and lymph node status, but did add prognostic information when controlling for tumor size.

AB - Angiogenesis in early stage breast cancer has been suggested to be an independent prognostic factor for metastasis and overall survival. We retrospectively studied 316 cases of early breast cancer with a mean follow-up period of 94 months to determine the role of angiogenesis as a prognostic factor in breast cancer utilizing a Factor VIII immuno-histochemical assay. In a univariate analysis, patients with microvessel counts in the lower 25th percentile had significantly better overall disease-free survival than patients in the upper quartiles (p <0.017). In a multivariate analysis of disease-free survival, microvessel counts did not add to prognostic information when controlling for estrogen receptor status and lymph node status, but did add prognostic information when controlling for tumor size.

KW - angiogenesis

KW - breast cancer

KW - counts

KW - microvessel

KW - prognostic factor

UR - http://www.scopus.com/inward/record.url?scp=0028063042&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028063042&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 1437

EP - 1445

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 6

ER -